FATE - Fate Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
No. of Analysts8888
Avg. Estimate-0.24-0.26-1.07-1.05
Low Estimate-0.27-0.29-1.2-1.52
High Estimate-0.17-0.17-0.69-0.47
Year Ago EPS-0.27-0.37-1.19-1.07
Revenue EstimateCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
No. of Analysts7776
Avg. Estimate2.37M1.34M6.15M8.25M
Low Estimate900k150k1.35M4.1M
High Estimate5.65M2.4M9M16.9M
Year Ago Sales1.06M1.03M4.74M6.15M
Sales Growth (year/est)123.60%30.50%29.70%34.10%
Earnings History3/30/20186/29/20189/29/201812/30/2018
EPS Est.-0.22-0.32-0.25-0.24
EPS Actual-0.27-0.37-0.31-0.25
Difference-0.05-0.05-0.06-0.01
Surprise %-22.70%-15.60%-24.00%-4.20%
EPS TrendCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.24-0.26-1.07-1.05
7 Days Ago-0.24-0.26-1.07-1.05
30 Days Ago-0.24-0.26-1.05-1.04
60 Days Ago-0.24-0.27-1.13-1.2
90 Days Ago-0.26-0.28-1.16-1.07
EPS RevisionsCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/A1
Up Last 30 DaysN/AN/AN/A1
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesFATEIndustrySectorS&P 500
Current Qtr.11.10%N/AN/A-0.02
Next Qtr.29.70%N/AN/A0.04
Current Year10.10%N/AN/A0.05
Next Year1.90%N/AN/A0.11
Next 5 Years (per annum)N/AN/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A